BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,092 | -20.5% | 21,737 | +0.1% | 0.06% | -14.5% |
| Q2 2023 | $1,373 | +21.9% | 21,717 | -13.2% | 0.07% | +38.0% |
| Q1 2023 | $1,126 | +2.7% | 25,020 | +0.1% | 0.05% | -5.7% |
| Q4 2022 | $1,096 | -99.9% | 25,006 | -0.3% | 0.05% | -33.8% |
| Q3 2022 | $1,654,000 | +9.4% | 25,085 | -16.2% | 0.08% | +21.2% |
| Q2 2022 | $1,512,000 | -32.7% | 29,946 | -14.8% | 0.07% | -25.0% |
| Q1 2022 | $2,245,000 | -46.3% | 35,146 | -9.9% | 0.09% | -31.8% |
| Q4 2021 | $4,181,000 | -24.6% | 39,029 | -27.7% | 0.13% | -27.9% |
| Q3 2021 | $5,548,000 | +18.0% | 53,954 | +1.0% | 0.18% | +14.0% |
| Q2 2021 | $4,702,000 | +1549.8% | 53,433 | +394.1% | 0.16% | +1862.5% |
| Q4 2015 | $285,000 | +126.2% | 10,815 | +83.3% | 0.01% | +100.0% |
| Q3 2015 | $126,000 | -17.6% | 5,900 | +1.7% | 0.00% | -20.0% |
| Q2 2015 | $153,000 | – | 5,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |